RedHill Biopharma reported $800K in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 110M 80M Aug/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
Cronos Group USD 958.02M 45.05M Mar/2026
RedHill Biopharma USD 1000K 4M Jul/2026